J2249 HCPCS Level II code: Injection, remimazolam, 1 mg
J2249 is the HCPCS code for “Injection, remimazolam, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2249Injection, remimazolam, 1 mg
Short description: Inj, remimazolam, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2249 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2023
Where J2249 sits
- 1J codesDrugs administered other than orally
- 2Active code J2249Injection, remimazolam, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2249 mean?
J2249 is the HCPCS code for “Injection, remimazolam, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2249?
CMS lists J2249’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2249
All J codesJ2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)J2210Injection, methylergonovine maleate, up to 0.2 mgJ2212Injection, methylnaltrexone, 0.1 mgJ2246Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mgJ2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mgJ2248Injection, micafungin sodium, 1 mgJ2250Injection, midazolam hydrochloride, per 1 mgJ2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mgJ2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mgJ2253Injection, midazolam (seizalam), 1 mgJ2260Injection, milrinone lactate, 5 mgJ2265Injection, minocycline hydrochloride, 1 mg